Abstract
Background: Breast carcinoma is one of the ten commonest worldwide malignancies. The objective of the
current study was to correlate the significance of prognostic markers and molecular subtypes with patients’ age
in carcinoma of female breast.
Material & Methods: A descriptive study was conducted at Department of Pathology, Peshawar Medical College,
Peshawar and Pakistan Institute of Medical Sciences, Islamabad. Sixty mastectomy specimens were selected
using a non-probability sampling method from 1st January, 2012 to 31st December, 2013. Histological type, tumor
size, tumor grade and lymph node status were determined. Estrogen receptor (ER), progesterone receptor (PR)
and Her-2/neu expression were evaluated immunohistochemically.
Results: Among these 60 patients, the mean age was 50.5±14.4 years. There were 26 (43.3%) patients with age
more than 50 years while 24 (40%) were between 40 and 50 years. Ten (16.7%) patients had age less than 40
years. Luminal A molecular subtype was observed in 50% in age groups 40 to 50 and above 50 years. The age
group above 50 years had more cases of luminal B (58%) and non-luminal (42%) types. Triple negative molecular
subtype is more common in age group between 40 and 50 years i.e. 57.1%.
Conclusions: It was concluded that age is an important factor in determining the aggressiveness of female breast
cancer along with other markers like, ER, PR and HER2/neu receptor status.
Naveed Sharif, Sajjad Ahmad, Muhammad Mumtaz Khan, Ahmareen Khalid, Sadaf Alam, Sara Ziaullah, Sabeen Nasir, Fozia Rauf. (2015) EFFECT OF AGE ON PROGNOSIS IN DIFFERENT MOLECULAR SUBTYPES OF FEMALE BREAST CARCINOMA, Gomal Journal of Medical Sciences , Volume 13, Issue 3.
-
Views
594 -
Downloads
49
